Pharmaceutical Industry Information Portal

HomeTagsInvestments

All posts by tag

Investments

Cogent Biosciences begins $125 million public offering

Cogent Biosciences, Inc., a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that it has commenced an underwritten public...

Bluejay Diagnostics shares down 31% after rising Thursday

Bluejay Diagnostics Inc. shares reversed course from Thursday's gains, dropping 31% to $1.12 one day after saying the Food and Drug Administration has agreed...

3D deep-learning research company Charm Therapeutics launches with $50m series A

CHARM Therapeutics (“CHARM”, “The Company”), announces today a $50M Series A financing co-led by F-Prime Capital and OrbiMed, with General Catalyst, Khosla Ventures, Braavos...

Code Biotherapeutics raises $75 Million to advance programs to treat and cure rare and prevalent genetic diseases

Code Biotherapeutics, Inc., (Code Bio), a biotechnology company pioneering targeted non-viral delivery of genetic medicines, today announced its upsized and oversubscribed Series A financing...

AI specialist Insilico raises $60m to launch AI-powered drug discovery robotics laboratory

Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that it has completed a $60 million Series D financing from...

Bristol Myers Squibb announces a $4.1 billion deal to acquire Turning Point Therapeutics

Pharmaceutical giant Bristol Myers Squibb Company announced a $4.1 billion deal for Turning Point Therapeutics Inc  on Friday morning, the first sizable acquisition for...
spot_img

Expert Articles

spot_img